- Home
- SIEB vs INBX Comparison
SIEB vs INBX Comparison
Compare SIEB & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- INBX
- Stock Information
- Founded
- SIEB 1886
- INBX 2010
- Country
- SIEB United States
- INBX United States
- Employees
- SIEB N/A
- INBX N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- SIEB Finance
- INBX Health Care
- Exchange
- SIEB Nasdaq
- INBX Nasdaq
- Market Cap
- SIEB 148.8M
- INBX 178.5M
- IPO Year
- SIEB N/A
- INBX 2020
- Fundamental
- Price
- SIEB $4.21
- INBX $15.69
- Analyst Decision
- SIEB
- INBX Hold
- Analyst Count
- SIEB 0
- INBX 1
- Target Price
- SIEB N/A
- INBX N/A
- AVG Volume (30 Days)
- SIEB 180.4K
- INBX 68.2K
- Earning Date
- SIEB 08-13-2025
- INBX 08-12-2025
- Dividend Yield
- SIEB N/A
- INBX N/A
- EPS Growth
- SIEB 117.05
- INBX N/A
- EPS
- SIEB 0.46
- INBX 111.58
- Revenue
- SIEB $92,064,000.00
- INBX $200,000.00
- Revenue This Year
- SIEB N/A
- INBX N/A
- Revenue Next Year
- SIEB N/A
- INBX N/A
- P/E Ratio
- SIEB $10.13
- INBX $0.14
- Revenue Growth
- SIEB 21.82
- INBX N/A
- 52 Week Low
- SIEB $1.41
- INBX $10.80
- 52 Week High
- SIEB $5.77
- INBX $17.79
- Technical
- Relative Strength Index (RSI)
- SIEB 39.36
- INBX 66.26
- Support Level
- SIEB $4.34
- INBX $14.19
- Resistance Level
- SIEB $4.71
- INBX $15.67
- Average True Range (ATR)
- SIEB 0.34
- INBX 0.84
- MACD
- SIEB -0.16
- INBX 0.13
- Stochastic Oscillator
- SIEB 4.88
- INBX 96.27
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.